• Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About

Home

Monthly Archives: June 2025

wegovy vs mounjaro

Wegovy vs. Mounjaro: A Head-On Comparison at the Dawn of Wegovy’s Launch in India

June 30, 2025
by official.ajinkya11@gmail.com Disease & DrugsHealth Tidings

30 June 2025Category:  Pharmaceutical Market Analysis I Drug Comparison & Reviews IObesity Therapeutics Written by:Priyanka Khamkar, MPharm, andVikas Londhe, MPharmReviewed By:Pharmacally Editorial Team Wegovy (Semag ...

Read More
0
ChatGPT Image Jun 29, 2025, 12_52_04 PM

Wearable Health Technology: Turning Pharmacovigilance from Reactive to Proactive and Predictive

June 29, 2025
by official.ajinkya11@gmail.com Research

29 June 2025Category:  Drug Safety | Health Technology | Digital HealthWritten by:Utkarsha Patil, M.PharmReviewed and Fact-Checked By: Vikas Londhe, MPharm Freepik.com Pharmacovigilance is the phase of clin ...

Read More
0
Yeztugo

“Gilead’s Yeztugo (Lenacapavir) Receives FDA Nod as First Twice-Yearly Injectable for HIV PrEP”

June 27, 2025
by official.ajinkya11@gmail.com New Drug Approval

27 June 2025Category: New Drug Approval I Sexual Health IHIV & Infectious DiseasesWritten By: Dewanshee Ingale BPharmReviewed By: Pharmacally Editorial Team Glilead In the landmark development, FDA has ...

Read More
0
amgen

Amgen’s Once-Monthly Maridebart cafraglutide (MariTide) Demonstrates Strong Efficacy in Obesity: Positive Phase 2 Maritime 1 Trial Results

June 26, 2025
by official.ajinkya11@gmail.com Clinical Trails

26 June 2025Category: Clinical Trial I Obesity & Metabolic Disorders IDiabetes and Weight lossWritten and Reviewed By:Vikas Londhe, MPharm Amgen logo In recent times, the focus has been shifted to next- ...

Read More
0
ChatGPT Image Jun 24, 2025, 11_56_23 AM

“CagriSema: A Powerful New Weight Loss and Diabetes Combination Therapy Emerges from REDEFINE-2 Trial”

June 24, 2025
by official.ajinkya11@gmail.com Clinical Trails

24 June 2025Category: Clinical Trial I Obesity & Metabolic Disorders IDiabetes and Weight lossMedically Written and Reviewed By: Vikas Londhe MPharm Generative AI The race to develop new treatments for ...

Read More
0
patch

FDA Issues Safety Warning: Transderm Scop (Scopolamine Transdermal System) Antinausea Patch May Cause Heat-Related Illness, Hospitalization, or Death

June 23, 2025
by official.ajinkya11@gmail.com Disease & Drugs

June 22, 2025Category: Drug Safety Alerts | FDA Updates | Patient SafetyWritten by: Priyanka Khamkar, MPharmReviewed By: Pharmacally Editorial Team Generative AI The U.S. Food and Drug Administration (FDA) ...

Read More
0
freepik__the-style-is-candid-image-photography-with-natural__37356

Rising Threat: the Latest Aspergillus fumigatus Outbreak in the U.S. and Global Precautions

June 21, 2025
by official.ajinkya11@gmail.com Health Tidings

Published on: 21 June 2025Category: Health News I Infectious Diseases & Outbreaks IFungal InfectionWritten By:Dewanshee Ingale, BPharmReviewed and Fact-Checked By:Pharmacally Medical News Team Source:Freepik.com ...

Read More
0
30442

Beetroot and Its Remarkable Health Benefits: A Natural Boost for Body Brain and Heart

June 20, 2025
by official.ajinkya11@gmail.com Food

Published on: 20 June 2025Category: Wellness I Functional Foods & NutraceuticalsWritten By: Dewanshee Ingale, BPharmReviewed and Fact Checked By: Samruddhi Jadhav B.Sc-Microbiology, MSc-Nutrition and Food Science (Clinical & Holistic Nutritionist) ...

Read More
0
freepik__artistic-representation-of-clostridioides-difficil__32689

Ibezapolstat: AcurX Pharmaceuticals First-in-Class Mechanism Antibiotic for Clostridioides difficile Infection Shows Promising Results in Phase 2b Trial

June 20, 2025
by official.ajinkya11@gmail.com Clinical Trails

Published On: 20 June 2025Category: Clinical Trial I Infectious Disease IGut and Gastrointestinal InfectionsWritten By: Pharmacally Medical News Desk. Source: Freepik.com Clostridioides difficile infection ...

Read More
0
freepik__the-style-is-candid-image-photography-with-natural__85026

Venclexta Falls Short in Late-Stage Trial for Higher-Risk Myelodysplastic Syndrome (MDS): Roche and AbbVie Release Results

June 18, 2025
by official.ajinkya11@gmail.com Disease & Drugs

Published: June 18, 2025Category: Clinical Trial | Hematology | OncologyWritten By: Team Pharmacally                                                                                             ...

Read More
0
  • 1
  • 2
  • 3
  • Next
  • Last

Recent Posts

  • FDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after Third Death from Liver Failure
  • “Repurposing Fenbendazole in Oncology: Hype vs. Hope in the Context of the ‘Joe Tippens Protocol'”
  • Topline Phase 3 Results of Hengrui Pharma and Kailera Therapeutics’ Dual Agonist HRS9531 Shows Promising Weight Loss: A Rising Competitor to Zepbound?
  • “FDA raises Ocular Toxicity Concerns over GSK’s Blenrep (Belantamab Mafodotin): A Setback for Multiple Myeloma Hope”
  • Sun Pharma Launches LEQSELVI™ in the U.S. for Severe Alopecia Areata after Patent Settlement

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025

About Us

  • About Us
  • Internship with us
  • Terms and Conditions

Categories

  • Clinical Trails
  • Disease & Drugs
  • Food
  • Health Tidings
  • Lifestyle
  • New Drug Approval
  • Research
  • Wellness
  • Women & Child Health

Pharmacally a brand of

MedCognize Communications (OPC) Pvt. Ltd.

Gat No. 405, Plot No. 17, Post-Nighoje, Near Faith Automation,

Opp. Anjali T Precision, Chakan Industrial Area, Pune 410501

Maharashtra, India

Contact No. - +91 9960598036

Email - contactus@pharmacally.com

  • About Us
  • Advisory Panel (Medical Experts)
  • About Founder
  • Source of Information

Follow Us -

Facebook Whatsapp Linkedin X-twitter
  • Internship with us
  • Advertise with us
  • Privacy Policy
  • Terms & Conditions

Subscribe to Newsletter -

SUBSCRIBE

Follow Us -

Facebook Whatsapp Linkedin X-twitter

Disclaimer: The content provided on the website is for information purposes only and is not intended as medical advice, diagnosis or treatment. Always seek doctors and other health provider’s advice in person regarding your any medical query or condition.

Copyright © 2025 Pharmacally | Designed by TEXPERT MENTOR

Shopping Basket